Nalaganje...
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD
Recently, treatment with BET (bromodomain and extraterminal) protein antagonist (BA) such as JQ1 has been shown to inhibit growth and induce apoptosis of human AML cells, including those expressing FLT3-ITD. Here, we demonstrate that co-treatment with JQ1 and the FLT3 tyrosine kinase inhibitor (TKI)...
Shranjeno v:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185220/ https://ncbi.nlm.nih.gov/pubmed/25053825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-14-0258 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|